Search Results - "Gradecki, Sarah E."

Refine Results
  1. 1

    Concordance of PD-L1 Expression Between Core Biopsy and Resection Specimens of Non–Small Cell Lung Cancer by Gradecki, Sarah E, Grange, Jacob S, Stelow, Edward B

    Published in The American journal of surgical pathology (01-08-2018)
    “…The heterogeneity of programmed death ligand 1 (PD-L1) expression in non–small cell lung carcinomas (NSCLCs) is well studied; however, the method of tissue…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Cutaneous mucormycosis with suspected dissemination in a patient with metastatic adrenocortical carcinoma by Dar, Nakul, Wills, Abigail, Berg, Scott, Gradecki, Sarah E., Cropley, Thomas G., Guffey, Darren

    Published in Medical mycology case reports (01-06-2024)
    “…Mucormycosis is a frequently lethal fungal infection that most commonly affects patients with poorly controlled diabetes or other immunosuppressed states. We…”
    Get full text
    Journal Article
  4. 4

    PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna by Gradecki, Sarah E, Valdes‐Rodriguez, Rodrigo, Wick, Mark R, Gru, Alejandro A

    Published in Histopathology (01-06-2021)
    “…Aims Lentigo maligna (LM), the most common type of melanoma in situ, is a diagnostically challenging lesion for pathologists due to abundant background…”
    Get full text
    Journal Article
  5. 5

    PRAME expression in 155 cases of metastatic melanoma by Gradecki, Sarah E., Slingluff, Craig L., Gru, Alejandro A.

    Published in Journal of cutaneous pathology (01-04-2021)
    “…Background PRAME (preferentially expressed antigen in melanoma) is a promising immunohistochemical marker in distinguishing benign from malignant primary…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Case Report: Dynamic overlap of melanoma, sarcoidosis, and targeted therapy for BRAF-mutant melanoma by Dar, Nakul, Gradecki, Sarah E., Gaughan, Elizabeth M.

    Published in Frontiers in oncology (29-08-2023)
    “…Targeted therapies, including BRAF and MEK inhibitors, are valuable treatment options for patients with unresectable or metastatic BRAF V600-mutant melanoma…”
    Get full text
    Journal Article
  8. 8

    PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Potential Immunotherapeutic Target and Possible Diagnostic Pitfall by Coppock, Joseph D., Gradecki, Sarah E., Mills, Anne M.

    “…Preferentially expressed antigen in melanoma (PRAME) is a cancer testes antigen initially employed as a diagnostic marker for melanoma. Although negative in…”
    Get full text
    Journal Article
  9. 9

    An unusual case of sarcomatoid renal cell carcinoma presenting in the skin by direct extension at a laparoscopic port site by Gradecki, Sarah E., Gru, Alejandro A.

    Published in Journal of cutaneous pathology (01-07-2020)
    “…Although renal cell carcinoma (RCC) is known for its propensity to metastasize widely throughout the body, cutaneous metastases are uncommon and seen in less…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Diagnostic Efficiency in Digital Pathology: A Comparison of Optical Versus Digital Assessment in 510 Surgical Pathology Cases by Mills, Anne M, Gradecki, Sarah E, Horton, Bethany J, Blackwell, Rebecca, Moskaluk, Christopher A, Mandell, James W, Mills, Stacey E, Cathro, Helen P

    Published in The American journal of surgical pathology (01-01-2018)
    “…Prior work has shown that digital images and microscopic slides can be interpreted with comparable diagnostic accuracy. Although accuracy has been…”
    Get full text
    Journal Article
  14. 14

    IDO1 Expression in Melanoma Metastases Is Low and Associated With Improved Overall Survival by Lynch, Kevin T., Gradecki, Sarah E., Kwak, Minyoung, Meneveau, Max O., Wages, Nolan A., Gru, Alejandro A., Slingluff, Craig L.

    Published in The American journal of surgical pathology (01-06-2021)
    “…Indoleamine 2-3 dioxygenase 1 (IDO1) expression may contribute to immunologic escape by melanoma metastases. However, a recent clinical trial failed to…”
    Get full text
    Journal Article
  15. 15

    Glioma-Associated Oncogene-1 Expression in Basal Cell Carcinoma and Its Histologic Mimics by Gradecki, Sarah E., Eid, Mary V., Pramoonjago, Patcharin, Wick, Mark R.

    Published in The American journal of dermatopathology (01-09-2021)
    “…Basal cell carcinoma (BCC) is the most common skin cancer, and it has numerous histologic mimics with variable prognoses and treatments. Although some…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Secondary Burn Progression Mitigated by an Adenosine 2A Receptor Agonist by Haywood, Nathan, Byler, Matthew R, Zhang, Aimee, Rotar, Evan P, Money, Dustin, Gradecki, Sarah E, Ta, Huy Q, Salmon, Morgan, Kron, Irving L, Laubach, Victor E, Mehaffey, J Hunter, Roeser, Mark E

    Published in Journal of burn care & research (05-01-2022)
    “…Abstract Current burn therapy is largely supportive with limited therapies to curb secondary burn progression. Adenosine 2A receptor (A2AR) agonists have…”
    Get full text
    Journal Article
  18. 18
  19. 19

    PRAME Expression in Endometrioid and Serous Endometrial Carcinoma: A Potential Immunotherapeutic Target and Possible Diagnostic Pitfall by Coppock, Joseph D., Gradecki, Sarah E., Mills, Anne M.

    “…Preferentially expressed antigen in melanoma (PRAME) is a cancer testes antigen initially employed as a diagnostic marker for melanoma. Although negative in…”
    Get full text
    Journal Article
  20. 20